News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO): Stock Split Information



12/10/2013 9:23:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bagsvaerd, Denmark, Dec. 10, 2013 (GLOBE NEWSWIRE) -- As communicated on 31 October 2013 in connection with the release of Novo Nordisk's financial results for the first nine months of 2013, Novo Nordisk's Board of Directors has approved a stock split of the Novo Nordisk B shares listed on NASDAQ OMX Copenhagen and of the American Depositary Receipts (ADRs) listed on New York Stock Exchange (NYSE). The trading unit of the Novo Nordisk B shares listed on the stock exchange in Copenhagen will be changed from DKK 1 to DKK 0.20. The ratio of B shares to ADRs listed on NYSE will remain 1:1. These changes in trading units will take effect as of 2 January 2014 for the Novo Nordisk B shares and as of 9 January 2014 for the ADRs.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES